Is Semiconductor Short Interest Signaling a Return to Market Highs?
The June 14 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks increased.
All Work
Chris Lange
How Micron Pulled Ahead in Q3
Micron released its fiscal third quarter financial results after the markets closed on Tuesday. The company said that it had $1.05 in earnings per share (EPS) and $4.79 billion in revenue, compared with consensus…
What to Expect When Micron Reports After the Close
Micron Technology is scheduled to release its fiscal third-quarter financial results after the markets close on Tuesday.
Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?
Allergan shares jumped on Tuesday after the company announced that it would be acquired by AbbVie in a cash and stock transaction valued at roughly $63 billion.
Is It Time to Back Off the Shopify Craze?
Shopify has proven to be one of the most outstanding stocks of 2019 thus far, but one analyst believes it’s time for buyers to take a breather.
Why Akorn Is in Trouble With the FDA Again
Akorn shares dipped on Tuesday after the firm announced that it received a warning letter from the FDA related to the inspection of its Somerset, New Jersey, manufacturing facility in July and August of…
Why China Is Turning Away From Big US Tech and Looking Within
China's PingCAP is competing in a sector traditionally dominated by companies such as Oracle and IBM, thus demonstrating the nation’s resurgent desire to "buy China."
Why All the Good News Is Priced Into Roku’s Stock
Roku has built an exceptional platform on the back of its players, and as it expands in the rapidly growing Smart TV category, it has positioned itself as best in class for OTT advertising…
Big Biotechs Scare Off Short Sellers
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Why the Cuba Ban Impact Looks Overdone in Cruise Line Stocks
Back in 2015, the Obama administration opened up travel to Cuba. This was great for cruise lines because they had another destination for passengers to book. However, recent developments have raised questions in this…
What to Expect When FedEx Reports Tuesday
Transportation giant FedEx is scheduled to release its fiscal fourth-quarter financial results after the markets close on Tuesday.
How Minerva Neursciences Is Outsmarting Insomia
Minerva Neurosciences saw its shares jump on Monday after the firm announced results from a trial related to an insomnia treatment.
Nike, Micron, Walgreens, FedEx, and More Major Earnings Coming This Week
We have included the consensus earnings estimates, as well as the stock price and trading history. Be advised that the earnings and revenue estimates may change ahead of the formal reports, and some companies…
5 Dow Stocks Not Allowing the DJIA a Proper Rally
Running a screen on Finviz reveals that about two-thirds of the Dow’s 30 components are up by double-digit percentages in 2019. Although five of the 30 components still are basically down so far in…
Why These Two Analysts See Massive Upside for Tesla
Tesla has faced a rough 2019 with a fatal autopilot accident and some analysts calling for its demise, but this could all change according to a couple different reports that came public on Friday.
Why One Analyst Sees Significant Upside at Facebook in Crypto Endeavor
Although Facebook had a rough run in 2018 amid security breaches, congressional hearings, and privacy issues, the company has done significantly better this year. In fact recent reports of Facebook launching its own cryptocurrency…
Google and Tablets Just Don’t Mix
While many consumers are familiar with the Apple iPad or the Microsoft Surface, Alphabet Inc. (NASDAQ: GOOG) tablets don’t quite measure up. This tech giant has tried again and again with the Nexus and…
Varonis Subscription Model Could Bring Almost 40% Upside Potential
Varonis Systems offers a broad range of robust features and unique functionalities that differentiates it from traditional data security offerings via its platform. This firm continues to be in the sweet spot of purchasing…
FDA Ignites Ocular Inflammation Treatment Dextenza in Most Recent Approval
Ocular Therapeutix shares jumped on Friday after the firm announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Dextenza to include the treatment of ocular inflammation…
Should CarMax Get More Credit for Q1 Earnings?
CarMax released its fiscal first quarter financial results before the markets opened on Friday. The company said that it had $1.59 in earnings per share (EPS) and $5.37 billion in revenue, compared with consensus…